Back

Investigation of biomarker response to SGLT2 Inhibition in heart failure (SiN-HF)

30 August 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Diagnosis and biomarkers of heart failure Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Patrick Savage

Belfast Health and Social Care Trust, Belfast (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor Y. Okuno (Kumamoto, JP)
Abstract
Presentation thumbnail
Doctor M. Vidak (Zagreb, HR)
Abstract Slides Video
Presentation thumbnail
Doctor G. Aleshcheva (Berlin, DE)
Abstract Slides
Presentation thumbnail
Mr J. Malinowski (Warsaw, PL)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Diagnosis and biomarkers of heart failure

The Event

Event poster

ESC Congress 2025

30 August 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Novel epigenetic mapping in cell-free DNA for detection of changes during sodium glucose cotransporter 2 inhibitors (SGLT2I) treatment in heart failure patients
thumbnail
Congress Presentation
Safety of SGLT2-Inhibitors in cardio-oncology patients with heart failure undergoing cancer treatment
thumbnail
Congress Presentation
Predictors of worsening kidney function and their relation to SGLT2 inhibitor dapagliflozin administration in type 2 diabetes mellitus patients with chronic heart failure

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources